Quote | Super Quote
Corporate Announcement Search
All Stock 
Category 
Period:
Specific Date     From   To
Latest Corporate Announcement
Date Code Name Document
23/05/2024 22:5609988BABA-SWOVERSEAS REGULATORY ANNOUNCEMENT
23/05/2024 22:5402147ZHENGWEI GROUPCLARIFICATION ANNOUNCEMENT - PLACING OF NEW SHARES UNDER GENERAL MANDATE
23/05/2024 22:4806600SCICLONE PHARMAANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE
23/05/2024 22:4806600SCICLONE PHARMAOPTION OFFER FORM OF ACCEPTANCE
23/05/2024 22:4700390CHINA RAILWAYAn announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
23/05/2024 22:4602500VENUS MEDTECH-B(1) QUARTERLY UPDATE ON RESUMPTION PROGRESS; AND (2) CONTINUED SUSPENSION OF TRADING
23/05/2024 22:4606600SCICLONE PHARMAWHITE FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, 19 JUNE 2024 (OR AT ANY ADJOURNMENT THEREOF)
23/05/2024 22:4406600SCICLONE PHARMAPINK FORM OF PROXY FOR THE COURT MEETING TO BE HELD ON WEDNESDAY, 19 JUNE 2024 (OR AT ANY ADJOURNMENT THEREOF)
23/05/2024 22:4300390CHINA RAILWAYAn announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
23/05/2024 22:4106600SCICLONE PHARMANOTICE OF EXTRAORDINARY GENERAL MEETING
23/05/2024 22:4101894HANG YICK HLDGSPLACING OF NEW SHARES UNDER GENERAL MANDATE
23/05/2024 22:4008039CHINA COME RIDE2023/2024 INTERIM REPORT
23/05/2024 22:4008069FLYDOO TECHLetter to Non-registered Shareholder - Electronic Dissemination of Corporate Communications
23/05/2024 22:3906600SCICLONE PHARMANOTICE OF COURT MEETING
23/05/2024 22:3906600SCICLONE PHARMA(1) PROPOSAL FOR THE PRIVATISATION OF SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED BY SILVER PEGASUS INVESTMENT LIMITED BY WAY OF A SCHEME OF ARRANGEMENT (UNDER SECTION 86 OF THE COMPANIES ACT) (2) PROPOSED WITHDRAWAL OF LISTING OF SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED (3) SPECIAL DEAL RELATING TO ROLLOVER ARRANGEMENTS
23/05/2024 22:3900390CHINA RAILWAYAn announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
23/05/2024 22:3808106SHENGHUA LANDEANNOUNCEMENT - (1) RESIGNATION OF EXECUTIVE DIRECTOR; (2) NOMINATION OF EXECUTIVE DIRECTOR; AND (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
23/05/2024 22:3808069FLYDOO TECHLetter to Registered Shareholder - Electronic Dissemination of Corporate Communications and Reply Form
23/05/2024 22:3800136CHINA RUYINext Day Disclosure Return
23/05/2024 22:3708039CHINA COME RIDEANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36  
Remark: The above is the latest announcements within Today.
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.